KnowBe4’s Team of Cybersecurity Experts Release Predictions for 2022
KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, today announced its 2022 cybersecurity predictions from its team of industry experts.
The predicted cybersecurity trends for 2022 include:
Nuclear Ransomware 3.0
A trend that is currently building for the future on the side of the bad actor is that ransomware gangs are morphing into "everything gangs." Instead of just doing ransomware and data exfiltration, they are doing cryptomining, botnet creation, DDoS attacks, etc. The attack gangs of the future will look at every new victim as a pot of gold and try to figure out what to do and in which order to maximize financial value extraction.
New Malware Family: Not the Kind You Would Welcome Into Your Home
A new dangerous and persistent metamorphic malware family called “Tardigrade” is a new strain of Windows malware. It can constantly adapt to avoid detection and was first found targeting the biotech industry, including the infrastructure behind vaccine manufacturing, according to security researchers. This “metamorphic” ability prevents the malware from leaving a consistent signature behind, making it very hard for antivirus programs to spot. It contains the sneaky ability to spread both via phishing emails and USB devices.
Meta, the brand formerly known as Facebook, will entice masses to join the Metaverse. This will spawn a rush to establish dominance in the virtual world. As a result, hackers will also be drawn into this world, and we will see virtual attacks against both individuals and organizations. We will see an explosion of bad things happen to people and resources in the virtual world…virtual looting, virtual theft, account takeovers and more creative criminal exploits.
Disinformation Powered by Deep Fakes Will Cause a Political/Financial Circus
We will see a coordinated disinformation campaign that will rely heavily on deep fakes and manipulated footage to cause a political/financial circus. A deep fake could be used to manipulate a certain political party’s views by stating false opinions, promises or beliefs of a particular candidate. This could cause a chain reaction of certain organizations pulling funds from a political campaign based on statements made by the deep fake.
An Attack Against Cryptocurrency Will Hit Real World Economies
A major cryptocurrency will be attacked, causing billions of dollars in lost value either through direct theft or in value loss. Many individuals and organizations will be severely impacted and it will be referred to as the Black Crypto Day.
A Major EU Power Station/Utility Provider Will Be Crippled in a Novel Way Other Than Ransomware
Most likely somewhere in Eastern Europe, we will see some bad actors cut off your power, your gas and your water. Then as you watch in horror as your phone, tablets and laptop batteries die, they will hand out an olive branch that many will be ready to accept, but at what cost?
Someone Will Hack Back the Wrong Bad Actor and Trigger an International Incident
An overly-eager security researcher will think they have identified the culprit behind a major attack. In an act of retaliation, they will hack back only to discover they did not attribute the attack correctly. This will cause a major international incident and the organization responsible will be placed under extreme scrutiny.
The Rise of Dark Economy M&A
A lot of criminal gangs have become extremely wealthy. In fact, some shady organizations are large enough to be listed on a stock exchange. So, we will see a more formalized dark economy emerge with some M&A activity taking place as some gangs will look to cash-in by selling their organization while others look to grow in capability and reach.
When AI Goes Wrong In 2022
We’ll see the first wave of intelligent attack bots. The future is good threat hunting bots versus bad bots and the best algorithm wins.
“In many ways, it seems as if things are getting worse for cybersecurity professionals who are trying their best to protect their organizations,” said Stu Sjouwerman, CEO, KnowBe4. “But I think we are starting to see more of a focus on the human element, including human behavior, of cybersecurity protection measures. This is a positive shift in direction because people can implement all of the technical tools and controls in the world, but if they do not focus their efforts on the human layer of security, they are going to run into challenges. At the end of the day, a strong security culture is what truly matters and what we will see organizations focused on as we move into 2022.”
The predicted trends were collected from KnowBe4’s global team of security awareness advocates who are experts with decades of experience in the cybersecurity field. For more information on KnowBe4’s team of experts, visit https://www.knowbe4.com/security-awareness-training-advocates.
KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, is used by more than 44,000 organizations around the globe. Founded by IT and data security specialist, Stu Sjouwerman, KnowBe4 helps organizations address the human element of security by raising awareness about ransomware, CEO fraud, and other social engineering tactics through a new-school approach to awareness training on security. Kevin Mitnick, an internationally recognized cybersecurity specialist and KnowBe4's Chief Hacking Officer, helped design the KnowBe4 training based on his well-documented social engineering tactics. Tens of thousands of organizations rely on KnowBe4 to mobilize their end users as their last line of defense.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Specifica Validates Best-in-Class Status for in vitro Antibody Discovery Platform in Two Key Peer Reviewed Publications29.1.2022 02:00:00 EET | Press release
Specifica, a privately held antibody engineering company focused on innovative in vitro antibody library and discovery tools, announced the publication of two peer-reviewed articles describing its Generation 3 Antibody Discovery Platform1,2. Antibodies are the fastest growing class of therapeutics, representing nine of the top twenty best-selling drugs3. The global antibody therapy market is projected to grow from $178.50 billion in 2021 to $451.89 billion in 2028 at a CAGR of 14.1%4. Traditionally, therapeutic antibodies have been generated by harvesting immune responses, either from in-bred or transgenic mice, or from immune human subjects. Although there has been a long-standing interest in using in vitro antibody library approaches that avoid the use of animals, there have been two main concerns with antibodies from in vitro libraries: binding affinities tend to be lower, and poor developability characteristics are common, complicating their development as successful drugs. As desc
ADVA Optical Networking SE: Acorn HoldCo, Inc. reaches minimum acceptance threshold for its public exchange offer to all shareholders of ADVA Optical Networking SE29.1.2022 01:45:00 EET | Press release
ADTRAN, Inc. today announced that by the end of the acceptance period on January 26, 2022, 24:00 hours (local time Frankfurt am Main), the voluntary public takeover offer of Acorn HoldCo, Inc. (“Bidder”) to all shareholders of ADVA Optical Networking SE (“ADVA“) has been accepted for more than 60% of all ADVA shares entitled to voting rights and existing as of October 31, 2021. The minimum acceptance threshold has therefore been reached. The final result as at the end of the acceptance period is expected to be published on January 31, 2022. ADTRAN, Inc. and ADVA have thus reached yet another important milestone for the merger of the two companies and have come closer to their goal of creating a leading company in the field of optical transmission technology for enterprise, access and wide-area networks. The consummation of the public exchange offer continues to be subject to closing conditions not yet fulfilled, especially foreign direct investment approval in Germany. ADVA shareholder
causaLens Raises $45m Series A to Scale Human-centered AI That Understands Cause-and-effect28.1.2022 17:46:00 EET | Press release
causaLens, the London deep tech company delivering the future of AI, has raised a $45m Series A round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220126005888/en/ The causaLens co-founders, Dr. Maksim Sipos, CTO, on the left, and Dr. Darko Matovski, CEO, on the right. (Photo: Business Wire) causaLens is the pioneer of Causal AI - the only AI technology quantifying cause-and-effect relationships to reason alongside humans in a manner that is trustworthy, explainable, and fair. Causal AI represents a giant leap ahead of current correlation-based AI technologies, which blindly extrapolate historical data and are unable to ask counterfactual questions — the ‘what ifs’ at the core of human imagination and creativity. causaLens’s no-code platform delivers far more accurate and reliable results, and allows humans and machines to work together for the first time. It is trusted by decision makers across finance, industry, technol
Monrol Signing Agreement to License its GMP Grade Lu-177 n.c.a Production Technology to Curium28.1.2022 15:47:00 EET | Press release
Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has today announced it has signed an agreement with Curium Netherlands B.V (Curium) to license its GMP grade medical radioisotope, no-carrier-added 177Lu (n.c.a. 177Lu) cutting-edge production technology LuMagic®. This agreement will enable transfer of relevant equipment and supply from Monrol to Curium. Monrol is one of the few producers of Lutetium-177 n.c.a worldwide, having uninterrupted worldwide supply capabilities. Monrol Lu-177 n.c.a production process is an exclusive processing technology having cleaner and safer production method with stable isotope enrichment capability. Curium planning to manufacture the product Lu-177 n.c.a in its Petten production facility, Netherlands. This licence is offering significant opportunities both for Curium; one of the world’s largest nuclear medicine companies and Monrol; a company which develops, manufactures, and distributes world-class radiopharmaceutical products, radioisotopes to improve qu
CHMP issues positive opinion to expand Jardiance (empagliflozin) indication based on unprecedented benefit in adult heart failure patients with preserved ejection fraction28.1.2022 15:26:00 EET | Press release
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Jardiance® (empagliflozin) for the treatment of adults with symptomatic chronic heart failure, Boehringer Ingelheim and Eli Lilly and Company announced today.1 Empagliflozin was previously approved for the treatment of adults with symptomatic chronic heart failure with reduced ejection fraction (HFrEF).4 If approved, the positive opinion would expand this indication to be applicable for adults across the full spectrum of left ventricular ejection fraction (LVEF), including preserved ejection fraction (HFpEF). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220127005861/en/ “For the very first time, we now have a treatment that will improve clinical results across the full spectrum of heart failure patients – regardless of ejection fraction,” said Professor Stefan Anker, Heart Failure Car
Schlumberger DELFI Digital Platform Selected by Northern Lights JV for CO2 Project28.1.2022 15:00:00 EET | Press release
Schlumberger will deploy the DELFI* cognitive E&P environment on the Norwegian CO2 project by the Northern Lights Joint Venture (NL), to streamline subsurface workflows and longer-term modeling and surveillance of CO2 sequestration. NL was established to develop the world’s first open-source CO2 transport and storage infrastructure, providing accelerated decarbonization opportunities for European industries, with an ambition to store up to 5 million tonnes of CO2 per year based on market demand. For CO2 transportation and storage, Schlumberger digital solutions are used for subsurface characterization and dynamic reservoir simulation, which are key to understanding storage site capacity and the potential for injecting and containing fluids. They are also used for development planning, operations, appraisals, and monitoring purposes. “Northern Lights has recognized the huge potential of Schlumberger’s digital technology to fast-track decision making and de-risk CO2 transportation and st
Pixis Appoints Neel Pandya as the CEO for Europe Business, in Addition to APAC28.1.2022 14:28:00 EET | Press release
Pixis (formerly known as Pyxis One), a leading provider of contextual codeless AI infrastructure for complete marketing optimization, today appointed Neel Pandya as the Chief Executive Officer of its operations in Europe, in addition to his responsibilities of leading the APAC business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220128005166/en/ Neel Pandya joined Pixis as the CEO of APAC in its Bengaluru office after exiting L'Oréal. (Photo: Business Wire) Neel joined Pixis in its Bengaluru office in July 2021 as the CEO of APAC, bringing immense change and progress to the way Pixis operates, and greatly streamlining expansions in the APAC region. Under his leadership, Pixis witnessed a 185% growth in revenue in the APAC region, with India independently recording a 150% of growth. Over the last 7 months, in addition to greatly stabilizing customer churn Neel has also been instrumental in adding close to 30 new enterpris
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom